Re: Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-directed Intergroup Study (S8710)
- PMID: 22682824
- DOI: 10.1016/j.juro.2012.03.067
Re: Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-directed Intergroup Study (S8710)
Comment on
-
Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710).BJU Int. 2011 Sep;108(5):693-9. doi: 10.1111/j.1464-410X.2010.09900.x. Epub 2010 Nov 24. BJU Int. 2011. PMID: 21105991 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources